Amrize Ltd (NYSE:AMRZ) Stock Has Consensus Target Price of $50.00 According to Brokerages

Amrize Ltd (NYSE:AMRZ – Get Free Report) has been given an average recommendation of “Hold” by the nineteen research firms that are presently covering the company, Marketbeat reports. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $49.12.

Several brokerages have recently commented on AMRZ. Oppenheimer decreased their price target on Amrize from $62.00 to $55.00 and set an “outperform” rating on the stock in a research note on Friday, September 18th. Stephens dropped their price objective on Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a research note on Wednesday, August 12th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $60.00 price objective on shares of Amrize in a report on Monday, September 21st. Barclays reduced their price objective on Amrize from $55.00 to $40.00 and set an “equal weight” rating for the company in a report on Monday. Finally, JPMorgan Chase & Co. decreased their target price on Amrize from $52.00 to $48.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 13th.

View Our Latest Analysis on Amrize

Amrize Stock Up 0.0%

Amrize stock opened at $39.45 on Friday. Amrize has a fifty-two week low of $35.78 and a fifty-two week high of $65.94. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. The company has a market capitalization of $21.82 billion, a P/E ratio of 18.18, a PEG ratio of 1.40 and a beta of 0.20. The stock has a 50-day simple moving average of $40.16 and a 200-day simple moving average of $48.28.

Amrize (NYSE:AMRZ – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%. The business had revenue of $3.49 billion for the quarter. Equities research analysts expect that Amrize will post 2.44 earnings per share for the current year.

Amrize Announces Dividend

The company also recently announced a dividend, which was paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th were issued a $0.11 dividend. The ex-dividend date was Tuesday, August 18th. Amrize’s dividend payout ratio is 5.07%.

Insider Activity at Amrize

In other news, CEO Jan Jenisch purchased 4,000 shares of the stock in a transaction dated Wednesday, September 2nd. The stock was acquired at an average cost of $42.50 per share, for a total transaction of $170,000.00. Following the completion of the acquisition, the chief executive officer directly owned 519,000 shares in the company, valued at $22,057,500. This represents a 0.78% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mario Gross acquired 3,568 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average cost of $46.60 per share, with a total value of $166,268.80. Following the transaction, the insider owned 38,485 shares of the company’s stock, valued at approximately $1,793,401. The trade was a 10.22% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 48,983 shares of company stock worth $2,158,755 over the last three months. Company insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Brookstone Capital Management purchased a new stake in Amrize during the third quarter valued at about $208,000. Revisor Wealth Management LLC increased its stake in Amrize by 25.0% during the third quarter. Revisor Wealth Management LLC now owns 7,785 shares of the company’s stock worth $293,000 after acquiring an additional 1,557 shares during the last quarter. IFP Advisors Inc raised its holdings in shares of Amrize by 1,707.3% in the 3rd quarter. IFP Advisors Inc now owns 1,988 shares of the company’s stock worth $74,000 after purchasing an additional 1,878 shares during the period. Peddock Capital Advisors LLC raised its holdings in shares of Amrize by 3.9% in the 3rd quarter. Peddock Capital Advisors LLC now owns 21,017 shares of the company’s stock worth $786,000 after purchasing an additional 790 shares during the period. Finally, Allied Investment Advisors LLC raised its holdings in shares of Amrize by 10.1% in the 3rd quarter. Allied Investment Advisors LLC now owns 264,812 shares of the company’s stock worth $9,901,000 after purchasing an additional 24,363 shares during the period.

About Amrize

(Get Free Report)

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.

Further Reading

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.